Protein Interaction Mapping via Mutant Library Affinity Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for epitope and paratope mapping are inefficient and costly, particularly in crowded IP spaces where differentiating novel antibodies from existing ones is challenging, and there is a need for high-throughput characterization of protein-protein interactions.

Innovation Solution

A method utilizing site saturation mutagenesis and high-throughput screening to characterize the interactive surfaces of protein binding partners, identifying compensatory mutations through the AlphaSeq platform, which measures affinity values between libraries of wild-type and mutant polypeptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If exhaustive site saturation mutagenesis and high-throughput screening are used to characterize protein-protein interactions, then measurement precision and productivity are improved, but device complexity and loss of substance increase

Engineering Contradiction:
Improvecharacterization precisionVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The method segments the protein-protein interaction characterization into two separate libraries: one containing mutations in the first protein and another containing mutations in the second protein. This segmentation allows systematic high-throughput screening of all mutation combinations while maintaining manageable experimental complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from traditional single-protein mutagenesis to a two-dimensional screening approach by creating libraries of both proteins with mutations. This dimensional expansion enables comprehensive characterization of the interaction interface by testing all combinations of mutations across both proteins simultaneously.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If exhaustive site saturation mutagenesis and high-throughput screening are used to characterize protein-protein interactions, then measurement precision and productivity are improved, but loss of substance increases

Engineering Contradiction:
Improvescreening throughputVSAvoidprotein consumption
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The method creates multiple copies of protein libraries with different mutations, allowing high-throughput screening without requiring large amounts of each individual protein variant. The library approach enables parallel testing of numerous mutations using small amounts of material for each variant.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The screening platform is designed to universally test any combination of mutations from either library against any protein from the other library. This multi-functional capability allows the same experimental setup to characterize multiple protein-protein interactions using the same protein consumption budget.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If libraries of wild-type and mutant polypeptides are screened to identify compensatory mutations, then measurement precision is improved, but loss of time increases

Engineering Contradiction:
Improveaffinity measurement accuracyVSAvoidscreening duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The high-throughput screening platform continuously measures affinity values for all combinations of mutations from both libraries in a single experimental run. This continuous measurement approach eliminates the need for sequential testing of individual mutations, thereby maintaining high measurement precision while reducing total screening time.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS20260079163A1Method for characterizing and engineering protein-protein interactions
Publication Date: 2026.03.19 A ALPHA BIO INC
  • US20260079163A1 patent drawing
  • US20260079163A1 patent drawing
  • US20260079163A1 patent drawing

AI summary

Characterization of the binding dynamics at the interface between any two proteins that specifically interact plays a role in myriad biomedical applications. The methods disclosed herein provide for the high-throughput characterization of the specific interaction at the interface between two protein binding partners and the identification of functionally significant mutations of one or both protein binding partners. For example, the methods disclosed herein may be useful for epitope and paratope mapping of an antibody-antigen pair, which is useful for the discovery and development of novel therapies, vaccines, diagnostics, among other biomedical applications.